cancer – Page 10 – media

‘Precision Medicine’ may not always be so precise

Precision Medicine in oncology, where genetic testing is used to determine the best drugs to treat cancer patients, is not always so precise when applied to some of the world's more diverse populations, according to a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, and the Keck School of Medicine of the University of Southern California (USC).
- Source: worldpharmanews
- 549
- November 6, 2017
cancer oncology precision medicine Researches
Scientists discover 27 genes that could halt cancer

From an analysis of more than 2,000 tumors spanning 12 types of human cancer, scientists have identified 27 new genes that could stop the disease in its tracks.
- Source: medicalnewstoday
- 676
- November 2, 2017
cancer Researches suppressor genes tumor
Surgeon diagnoses his own cancer with an iPhone

US vascular surgeon John Martin found cancerous cells in his own neck while testing a portable ultrasound device called Butterfly iQ.
- Source: cnet
- 522
- October 30, 2017
Butterfly iQ cancer Market Views ultrasound
Not Enough Participants

Patient participation in clinical trials for cancer patients has been in decline. Researchers determine the barriers prohibiting participation.
- Source: medicalnewsbulletin
- 704
- October 27, 2017
cancer Clinical Trials
Cancer cells killed off with diabetes drug

Scientists may have found an innovative way to kill off cancer cells in acute myeloid leukemia(AML), all the while preserving and regenerating healthy red blood cells.
- Source: medicalnewstoday
- 755
- October 24, 2017
AML anemia cancer leukemia Researches
‘Handful of changes’ make cancer

British scientists have worked out how many changes it takes to transform a healthy cell into a cancer.
- Source: bbc
- 800
- October 23, 2017
cancer herceptin inhibitor tumour
‘Synthetic gene circuit’ may improve effectiveness of cancer immunotherapy

Synthetic gene circuits that only trigger powerful, tumor-specific immune responses when they detect certain disease markers may help immunotherapies to fight cancer more effectively, according to a new study.
- Source: medicalnewstoday
- 690
- October 20, 2017
cancer immunotherapies Synthetic gene
Hormone therapy for prostate cancer increases cardiac risk

Androgen-deprivation therapy, which is a common treatment for prostate cancer, has been tentatively linked with an increased risk of cardiovascular disease. A new study solidifies these concerns.
- Source: medicalnewstoday
- 611
- October 19, 2017
cancer cardiovascular prostate Researches
FDA Okays Another CAR T-Cell Therapy

The FDA has approved a second chimeric antigen receptor (CAR) T-cell therapy for cancer: Kite Pharma's axicabtagene ciloleucel (Yescarta) for the treatment of certain types of refractory large B-cell lymphoma, the agency announced.
- Source: medpagetoday
- 743
- October 19, 2017
cancer CAR–T FDA New Approvals
ICR researchers demonstrate use of genetic test for prostate cancer therapy

Scientists from the Cancer Biomarkers laboratory team of the Institute of Cancer Research in the UK have carried out research to demonstrate the use of a quick genetic test for the targeted treatment of prostate cancer.
- Source: medicaldevice-network
- 643
- October 12, 2017
cancer genetic prostate Researches

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.